Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Infervision is a pioneering artificial intelligence company dedicated to transforming healthcare through advanced medical imaging analysis. For healthcare professionals like radiologists and clinicians, Infervision's AI-powered software acts as an intelligent assistant, significantly improving the speed and accuracy of detecting and diagnosing conditions such as lung cancer, stroke, and bone fractures from various medical scans (CT, X-ray, etc.). These tools help identify subtle abnormalities that might be missed, streamline workflows, and support more informed clinical decisions. For patients, this translates to the potential for earlier disease detection, more precise diagnoses, personalized treatment plans, and ultimately, better health outcomes.
The Beijing headquarters serves as the nerve center for Infervision's global operations, spearheading research and development in AI, formulating corporate strategy, managing international business, and housing key administrative and leadership functions.
Situated in Raycom Infotech Park in Haidian District, often dubbed 'China's Silicon Valley,' the HQ benefits from a rich ecosystem of tech companies, top-tier universities, and research institutions. The facilities are modern and equipped for cutting-edge AI development.
The work culture is likely dynamic, innovative, and research-intensive, fostering collaboration between AI scientists, medical experts, engineers, and business professionals. There's a strong emphasis on technological breakthroughs and translating them into impactful healthcare solutions.
Beijing's strategic location provides access to a large domestic healthcare market, a deep pool of AI talent, and robust government support for high-tech industries, making it crucial for Infervision's R&D and global expansion initiatives.
Infervision has established a significant global footprint, deploying its AI-powered medical imaging solutions in hospitals and healthcare institutions across Asia, North America, Europe, and other regions. The company supports its international operations through regional offices and local teams that handle sales, marketing, technical support, product localization, and regulatory compliance (such as FDA in the US, CE in Europe, NMPA in China, etc.). Infervision actively collaborates with medical professionals and researchers worldwide to advance its technology and tailor its applications to diverse clinical needs and healthcare systems.
Tower A, Raycom Infotech Park, No.2 Kexueyuan South Road, Haidian District
Beijing
Beijing
China
Address: Specific street address not readily publicly available; typically commercial office space in a business or medical technology hub.
To expand the adoption of Infervision's AI-powered medical imaging tools in North American healthcare systems, ensuring products meet local clinical needs and regulatory standards.
Address: Specific street address not readily publicly available; typically commercial office space in a key European business center.
To drive the integration of Infervision's AI solutions within European hospitals and clinics, collaborating with regional healthcare providers and adapting to diverse national healthcare frameworks.
Address: Specific street address not readily publicly available; typically commercial office space catering to technology and healthcare sectors.
To penetrate Japan's advanced medical technology market by providing tailored AI solutions that align with local healthcare standards, clinical practices, and regulatory expectations (e.g., PMDA).
Address: Specific street address not readily publicly available; typically commercial office space in a regional business hub.
To establish and grow Infervision's presence in key APAC markets, customizing AI solutions to address regional healthcare challenges and leverage opportunities for innovation.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Infervision' leadership includes:
Infervision has been backed by several prominent investors over the years, including:
Information on specific executive hires or exits for Infervision within the last 12 months is not widely publicized. As a private, rapidly growing technology company, team composition can evolve, but detailed public announcements are typically reserved for very senior C-suite changes or those with significant public market implications. No such major leadership changes have been broadly reported in the recent period.
Discover the tools Infervision uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Infervision likely utilizes standard corporate email address patterns. While the exact primary format is not publicly confirmed, common structures for tech companies include [first_initial][last]@[companydomain].com (e.g., jdoe@infervision.com) or [first].[last]@[companydomain].com (e.g., jane.doe@infervision.com).
[first_initial][last]@infervision.com or [first].[last]@infervision.com
Format
ckuan@infervision.com (Example for Chen Kuan, CEO, based on the [first_initial][last] pattern)
Example
75%
Success rate
PR Newswire • December 14, 2023
Infervision announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its InferRead DR Chest solution. This AI tool is designed to assist radiologists in reviewing adult chest X-rays by identifying suspicious lesions and abnormalities, including lung nodules and pneumonia, enhancing diagnostic capabilities....more
PR Newswire • May 4, 2023
Infervision obtained 510(k) clearance from the U.S. FDA for its InferRead ASPECTS.AI software. This AI solution aids clinicians in assessing stroke by automating the Alberta Stroke Program Early CT Score (ASPECTS) on non-contrast CT images, facilitating faster and more consistent evaluations for stroke patients....more
PR Newswire • February 8, 2022
Infervision announced the completion of its Series D2 financing round, co-led by Qiming Venture Partners and Goldman Sachs Asset Management. This funding aimed to accelerate research and development of its AI medical imaging solutions, expand its product portfolio, and bolster its global market expansion efforts....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Infervision, are just a search away.